FINETEK CO. LTD.

As of March 31, 2026, FINETEK CO. LTD. carries a market capitalization of 27.23B, placing it among publicly traded companies globally. Its enterprise value stands at 56.20B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, FINETEK CO. LTD. has 8.69M shares outstanding.

These figures are as of March 31, 2026. The price-to-sales ratio is 0.60, and the price-to-book ratio stands at 0.98.

These figures are as of March 31, 2026. The EV/Sales ratio of 1.24 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 56.20B versus a market cap of 27.23B, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, FINETEK CO. LTD. maintains a current ratio of 0.84, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 147.47, indicating elevated leverage, while an interest coverage ratio of -0.89 demonstrates limited ability to service its debt obligations.

Over the twelve months ended March 31, 2026, FINETEK CO. LTD. posted a negative return on equity (ROE) of -23.98, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -9.07, reflecting losses generated across the asset base. The company generates approximately 477.99M in revenue per employee across its workforce of 94.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 20.00 indicates how many times FINETEK CO. LTD. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, FINETEK CO. LTD. recorded 53.84M in income tax expense. The company reported a pretax loss of -8.20B and -7.58B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, FINETEK CO. LTD.'s stock has declined approximately 75.50% over the past 52 weeks. The 50-day moving average sits at 1,445.12, while the 200-day moving average is 2,846.43.

Over the twelve months ended March 31, 2026, FINETEK CO. LTD. generated 45.17B in revenue and converted that into -7.58B in net income, yielding earnings per share of -950.18. EBITDA reached -1.71B, while operating income came in at -4.98B.

As of March 31, 2026, FINETEK CO. LTD. holds 9.33B in cash and equivalents against 39.39B in total debt, resulting in a net debt position of 33.53B. Total book value stands at 27.80B, with working capital of -5.79B providing operational flexibility.

FINETEK CO. LTD. produced 1.78B in operating cash flow over the twelve months ended March 31, 2026. After subtracting -8.63B in capital expenditures, free cash flow totaled -6.84B - equivalent to -787.62 per share.

Over the twelve months ended March 31, 2026, FINETEK CO. LTD. posted a gross margin of 7.99, reflecting its pricing power and cost economics. The operating margin of -11.03 and net profit margin of -16.79 provide insight into operational efficiency.

Over the twelve months ended March 31, 2026, FINETEK CO. LTD. paid dividends of 0.01 per share. The dividend payout ratio of 0.00 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -25.12: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 5.32, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to FINETEK CO. LTD. shareholders.

FINETEK CO. LTD.'s most recent stock split took place on May 22, 2026 with a 5:1 split ratio.

As of March 31, 2026, FINETEK CO. LTD. has an Altman Z-Score of -0.74, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.